Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KCNN2 | Q9H2S1 | 2/20 | 0.33 |
| ▸ | KCNN3 | Q9UGI6 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25455910 | 0.89 | NPC1 (0.34) | NPC1ALDH1A1LMNAMAPTMAPK1 | |
| SCHEMBL25451756 | 0.87 | EDNRB (0.35) | KCNN2KCNN3 | |
| SCHEMBL25450660 | 0.83 | ALDH1A1 (0.35) | NPC1ALDH1A1LMNAMAPTMAPK1 | |
| SCHEMBL25451688 | 0.82 | LMNA (0.37) | LMNAMAPT | |
| SCHEMBL25451690 | 0.81 | LMNA (0.44) | LMNA | |
| SCHEMBL25450500 | 0.80 | LMNA (0.38) | NPC1ALDH1A1LMNAMAPTMAPK1 | |
| SCHEMBL25450446 | 0.79 | ALDH1A1 (0.36) | NPC1ALDH1A1LMNAMAPTMAPK1 | |
| SCHEMBL25517571 | 0.77 | LMNA (0.32) | NPC1ALDH1A1LMNAMAPTRAB9A | |
| SCHEMBL26836321 | 0.77 | CYP2A6 (0.43) | NPC1ALDH1A1LMNAMAPTMAPK1 | |
| SCHEMBL25451687 | 0.76 | EDNRB (0.35) | KCNN2KCNN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240130-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-27 | — | — | US | disclosed |
| US-11653558-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240130-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBPL3, LBR, RBM3 | NPC1 1729/4885ALDH1A1 1928/4885LMNA 338/4885 |
| US-11653558-B2 | Organic electroluminescent materials and devices | OSBPL3, LBR, LOXL3 | NPC1 1255/4885ALDH1A1 1600/4885LMNA 304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.